ASTRAZENECA PLC (NYSE: AZN)

Overview
current price
$188.70
$188.70
change
3.50 | 1.89%
3.50 | 1.89%
Yesterday's Close
185.20
open
188.47
volume
0.27 M
30d. avg volume.
1.80 M
1 day
187.62 - 189.10
52 weeks
66.16 - 212.71
p/e
90.78
beta
0.3699
market cap
287.23 B
dividend yield
1.73%
Industry
-
News and Commentary
Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report The Trump administration is reportedly preparing to announce 100% tariffs on pharmaceutical companies that have not secured pricing deals with the White House.
After Canada, Another US Ally Set To Revive Old Trade Ties With China: Report The UK and China are reportedly set to reinvigorate their 'golden era' business dialogue during Prime Minister Keir Starmer's visit to Beijing next week.
Walmart Joins Nasdaq-100, Teams Up With Google, Shares Surge Walmart Inc. (WMT
AstraZeneca Doubles Down On US Biologics Buildout As Drug Discovery Partnership Grows Hong Kong-based Harbour BioMed announced on Sunday an update and advancement of its global strategic collaboration with AstraZeneca Plc
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Medicaid, TrumpRx President Donald Trump on Thursday announced agreements with Eli Lilly and Co.
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...
Big Money Is Betting On Europe, Should You? 3 ETFs To Watch European fund managers are optimistic that rising economic growth will fuel a rally in the region's stocks.This bullishness is already reflected in perf...
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on...
AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It Takes China Investig... AstraZeneca Plc (AZN&nb...
StockTwits
StockTwits

Join now and unlock premium features